False resistance to antiparasitic drugs: Causes from shelf availability to patient compliance

Anti-Infective Agents in Medicinal Chemistry

Volumn 9, Issue 3, 2010, Pages 161-167

  Cabaret, Jacques ^a  

^a UR1282   (France)

Author keywords

Anthelmintic; Compliance; Counterfeit drug; Efficacy test; False resistance; Malaria; Nematode; Schistosoma

Indexed keywords

ALBENDAZOLE; AMODIAQUINE; ANTIPARASITIC AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; BENFLUMETOL; BENZIMIDAZOLE; BENZNIDAZOLE; CHLOROQUINE; DIHYDROARTEMISININ; IVERMECTIN; MEFLOQUINE; PRAZIQUANTEL; PROGUANIL; PYRIMETHAMINE; SULFADOXINE;

ANCYLOSTOMA; ANTIBIOTIC RESISTANCE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; ASCARIS LUMBRICOIDES; CHAGAS DISEASE; DIET; DRUG ABSORPTION; DRUG EFFICACY; DRUG METABOLISM; DRUG QUALITY; FECES ANALYSIS; FOLLOW UP; FOOD DRUG INTERACTION; GIARDIA LAMBLIA; HELMINTH; HELMINTHIASIS; HUMAN; IN VIVO STUDY; LEISHMANIA; LEISHMANIASIS; NEUROCYSTICERCOSIS; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SCHISTOSOMA; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TRICHURIS; TRYPANOSOMA CRUZI; WUCHERERIA BANCROFTI;

EID: 77954680030     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871521411009030161     Document Type: Article

References (47)

1. Savioli, L.; Albonico, M.; Engels, D.; Montresor, A. Progress in the prevention and control of schistosomiasis and soil-transmitted helminthiasis. Parasitol. Int., 2004, 53, 103-113.
2. Enyati, A.; Hemingway, J. Malaria management: past, present, and future. Annu. Rev. Entomol., 2010, 55, 569-591.
3. Silvestre, A.; Leignel, V.; Berrag, B.; Gasnier, N.; Humbert, J.F., Chartier, C.; Cabaret, J. Sheep and goat nematode resistance to anthelmintics: pro and cons among breeding management factors. Vet. Res., 2002, 33, 465-480.
4. Kaplan, R.M. Anthelmintic resistance in nematodes of horses. Vet. Res., 2002, 33, 491-508.
5. Albonico, M. Methods to sustain drug efficacy in helminth control programmes. Acta Trop., 2003, 86, 233-242.
6. Bloland P.B. Drug resistance in malaria. http://www.who. int/drugresistance/publications/WHO_CDS_CSR_DRS_2001_4/en / index.html. (Accessed December 30, 2009).
7. Hastings, I.M.; Korenromp, E.L.; Bloland, P.B. The anatomy of a malaria disaster: drug policy choice and mortality in African children. Lancet Infect. Dis., 2007, 7, 739-748.
8. Medley, G.F. Chemotherapy. In: Parasitic and Infectious Diseases: Epidemiology and Ecology, Scott, M.E.; Smith, G. Eds; Academic Press: San Diego, CA, 1994 pp. 141-157.
9. Skorping, A.; Read, A.F. Drugs and parasites: global experiments in life history evolution. Ecol. Lett., 1998, 1, 10-12.
10. Crameri, A.; Marfutt, J.; Mugittu, K.; Maire N.; Regös A.; Coppee J.Y.; Sismeiro, O.; Burki, R.; Huber, E.; Laubscher, D.; Puijalon, O., Genton, B.; Felger, I.; Beck, H.P. Rapid micro-array-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalarial drugs. J. Clin. Microbiol., 2007, 45, 3685-3691.
11. Stepniewska, K.; Chotivanich, K.; Brockman A.; Day, N.P.J.; White, N.J. Overestimating resistance in field testing of malaria parasites: simple methods for estimating high EC50 values using Bayesian approach. Malar. J., 2007, 6, 4.
12. Attaran, A.; Barnes, K.I.; Bate, R.; Binka, F.; d'Alessandro, U.; Fanello, C.I.; Garrett, L.; Mutabingwa, T.K.; Roberts, D.; Hopkins, S.C.; Talisuna, A.; Van Geertruyden, J.P.; Watkins, W.M. The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment. Lancet, 2006, 368, 247-252.
13. Maltezou, H.C. Drug resistance in visceral leishmaniasis. J. Biomed. Biotechnol., 2010, 2010, 617521.
14. [14] World Health Organistation. Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme manager. http://www.who.int/intestinal_worms/strategy/en/ (Accessed December 15, 2009).
15. Elard, L.; Cabaret, J.; Humbert J.F. PCR diagnosis of benzimidazole-susceptibility or -resistance in natural populations of the small ruminant parasite, Teladorsagia circumcincta. Vet. Parasitol., 1999, 80, 231-237.
16. Silvestre, A.; Sauve, C.; Cortet, J.; Cabaret, J. Contrasting genetic structures of two parasitic nematodes, determined on the basis of neutral microsatellite markers and selected anthelmintic resistance markers. Mol. Ecol., 2009, 18, 5086-5100.
17. Diawara, A.; Drake, L.J.; Suswillo, R.R.; Kihara, J.; Bundy, D.A.P., Scott, M.E.; Halpenny, C.; Stothard, J.R.; Prichard R.K. Assays to detect -Tubulin codon 200 polymorphism in Trichuris trichiura and Ascaris lumbricoides. PLoS Negl. Trop. Dis. 2009, 3(3): e397.
18. Bourguinat, C.; Ardelli, B.F.; Pion, S.D.S.; Kamgno, J.; Gardon, J.; Duke, B.O.L.; Boussinesq, M.; Prichard, R.K. P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol. Biochem. Parasitol., 2008, 158, 101-111.
19. Bourguinat, C; Pion, S.D.; Kamgno, J.; Gardon J., Duke B.O.L.; Boussinesq, M., Prichard R.K. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl. Trop. Dis., 2007, 1(1): e72.
20. Pion, S.D.; Nana-Djeunga, H.; Bourguinat, C.; Cabaret, J.; Charvet, C.; Gardon, J.; Kamgno, J.; Njiokou, F., Prichard, R.; Wanji, S.; Boussinesq, M. Dynamics of Onchocerca volvulus microfilarial loads of cameroonian patients submitted to repeated (5-23) ivermectin treatments over 14 years (1994-2007). Am. J. Trop. Med. Hyg., 2008, 79(6), 1156.
21. [21] Flohr, C.; Tuyen, L.N.; Lewis, S.; Minh, T.T.; Campbell, J.; Britton, J.; Williams, H.; Hien, T.T.; Farrar, J.; Quinnell, R. J. Low efficacy of mebendazole against hookworm in Vietnam: two randomized controlled trials. Am. J. Trop. Med. Hyg., 2007,76, 732-736.
22. Keiser, J.; Utzinger, J. Efficacy of current drugs against soiltransmitted helminth infections. Systematic review and meta-analysis. J. Am. Med. Assoc., 2008, 299, 1932-1948.
23. Geary, T.G.; Woo, K.; McCarthy, J.S.; Mackenzie, C.D.; Horton, J.; Prichard, R.K.; de Silva, N.R.; Olliario, P. L.; Lazdin-Helds, J.K.; Engels, D.A.; Bundy, D.A. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol., 2010, 40, 1-13.
24. Newton, P.; Green, M.; Fernandez, F.; Day, N.; White, N. Counterfeit anti-infective drugs. Lancet Infect. Dis., 2006, 6, 603-605.
25. Taylor, R.B; Shakoor, O.; Behrens, R.H.; Everard, M.; Low, A.S.; Wangboonskul, J.; Raid, R.G.; Kolawole, J.A. pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet, 2001, 357, 1933-1936.
26. Maponga, C.; Ondari, C. The quality of antimalarials: a study in selected African countries. WHO 2003, http:/whqlibdoc.who.hq/2003/WHO_EDM_PAR_2003.4.pdf (Accessed December 15, 2009).
27. Basco, L.K.; Ringwald, P.; Maléné, A.B.; Chandenier, J. False chloroquine resistance in Africa. Lancet, 1997, 350, 224.
28. Bate, R.; Coticelli, P.; Tren, R.; Attaran A. Antimalarial drug quality in the most severely malarious parts of Africa A six country study. PLoS One, 2008 3(5): e2132.
29. United Nations Office on Drugs and Crime. Transnational trafficking and the rule of law in West Africa: a threat assessment. 2009. http://www.unodc.org/unodc/publications-bydatehtml/West_Africa_Report_2009.pdf (Accessed January 5, 2010).
30. Albonico, M.; Mathema, P.; Montresor, A.; Khakurel, B.; Pandey, S.; Savioli, L. Comparative study of the quality and efficacy of originator and generic albendazole for mass treatment of soiltransmitted nematode infections in Nepal. Trans. R. Soc. Trop. Med. Hyg., 2007, 101, 454-460.
31. [31] Albonico, M.; Allen, H.; Chitsulo, L.; Engels, D.; Gabrielli, A.F; Savioli, L. Controlling soil-transmitted helminthiasis in pre-school age children through preventive chemotherapy. PLoS Negl. Trop. Dis., 2008, e(3): e126.
32. Quon, B.S.; Firszt, R.; Eisenberg, M.J. A comparison of brandname drug prices between Canadian-based Internet pharmacies and major US drug chain pharmacies. Ann. Intern. Med., 2005, 143, 397-403.
33. Dayan, A.D. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop., 2003, 86, 141-159.
34. Guo, L.Q.; Fukuda, K.; Ohta, T.; Yamazoe, Y. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab. Dispos., 2000, 28, 766-771.
35. Castro, N.; Gonzalez-Esquivel, D.F.; Lopez, M.; Jung, H. Comparative analysis of the influence of food and cimetidine in plasma levels of praziquantel. Rev. Invest. Clin., 2003, 55, 655-661.
36. Bittencourt, P.R.M.; Gracia, C.M.; Martins, R.; Fernandas, A.G.; Diekmann, H. W.; Jung, W. Phenytoin and carbamazepine decrease oral bioavailability of praziquantel. Neurology, 1992, 42, 493-499.
37. Mejia, M.E.; Fernandez Igartua, B.M.; Schmidt, E.E., Cabaret, J. Multispecies and multiple anthelminthic resistance on cattle nematodes in a farm in Argentina: the beginning of high resistance? Vet. Res., 2003, 34, 461-467.
38. Cabaret, J., Berrag, B. Faecal egg count reduction test for assessing anthelmintic efficacy: average versus individually based estimations. Vet. Parasitol., 2004,121, 105-113.
39. Albonico, M.; Engels, D.; Savioli, L. Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int. J. Parasitol., 2004, 34, 1205-1210.
40. Churcher, T.S.; Pion, S.D.S.; Osei-Atweneboana, M.Y; Prichard, R.K; Awadzi, K.; Bussinesq, M.; Collins, R.C.; Whitworth, J.A.; Basanez, M.G. Identifying sub-optimal responses to ivermectin in the treatment of river blindness. Proc. Natl. Acad. Sci. USA, 2009, 106, 16716-16721.
41. Gaba, S.; Cabaret, J.; Ginot, V.; Silvestre, A. The early drug selection of nematodes to anthelmintics: stochastic transmission and population in refuge. Parasitology, 2006, 133, 345-356.
42. Gunawardena, S.; Ismail, M.; Bradley, M.; Karunaweera, N. Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka. Trans. R. Soc. Trop. Med. Hyg., 2007, 101, 445-453.
43. Meyer, T.; Sekljic, H.; Fuchs, S.; Bothe, H.; Schollmeyer, D.; Miculka, C. Taste, a new incentive to switch to (R)-Praziquantel in schistosomiasis treatment. PLoS. Negl. Trop. Dis., 2009, 3(1): e357.
44. Pierron, J.P. Approche anthropologique du médicament: un objet symbolique. An anthropological approach to medication: the drug as a symbolic object. Ethique Santé, 2009, 6, 43-49.
45. Fainzang, S. Médicaments et société. Ethnologies/controverses, PUF: Paris, 2001.
46. Dimomfu, B.L.; Lubeji, D.K.; Noma, M.; Sékétéli, A.; Bousinesq, M. African programme for onchocerciasis control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan). Trans. R. Soc. Trop. Med. Hyg., 2007, 101, 674-679.
47. Yun, O.; Lima, M.A.; Ellman, T.; Chambi, W.; Castillo, S.; Flevaud, L.; Roddy, P.; Parreño, F.; Viñas, P.A.; Palma, P.P. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières. PLoS. Negl. Trop. Dis., 2009, 3(7): e488